LY2334737, CAS [[892128-60-8]]

Produktübersicht

• Artikelname: LY2334737, CAS [[892128-60-8]]
• Artikelnummer: BYT-ORB1303216
• Hersteller Artikelnummer: orb1303216
• Alternativnummer: BYT-ORB1303216-1, BYT-ORB1303216-1, BYT-ORB1303216-10, BYT-ORB1303216-100, BYT-ORB1303216-200, BYT-ORB1303216-25, BYT-ORB1303216-5, BYT-ORB1303216-50
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Alternative Synonym: anticancer, antiviral, Analog, Inhibitor, HEVs, HEV, Gemcitabine, HRV, HRVs, Enterovirus, EV-A71, inhibit, LY2334737, LY-2334737, LY 2334737, NucleosideAntimetabolite, Nucleoside Antimetabolite, Nucleoside Antimetabolite/Analog, orally, Rhinovirus, Virus Protease, VirusProtease

Produktbeschreibung

LY2334737 is an orally administered prodrug of the antimetabolite gemcitabine. It is designed to improve bioavailability and is used in oncology research to study its antitumor effects in both in vitro and in vivo experimental models.

Produkteigenschaften

• Molekulargewicht: 389.39
• Reinheit: >99.99% (May vary between batches)
• CAS Nummer: [892128-60-8]
• Formel: C17H25F2N3O5
• Target-Kategorie: Virus Protease,Nucleoside Antimetabolite/Analog

Anwendungsbeschreibung

• Anwendungsbeschreibung: Solubility: DMSO:45 mg/mL (115.57 mM),10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.14 mM)